ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer

Ren, Xiaoli; Xiao, Jianbiao; Zhang, Wanning; Wang, Feifei; Yan, Yongrong; Wu, Xuehui; Zeng, Zhicheng; He, Yumei; Yang, Wei; Liao, Wangjun; Ding, Yanqing; Liang, Li*南方医科大学
Cell Death & Disease2021-5-13DOI: 10.1038/s41419-021-03698-5
15被引18阅读
引用收藏
分享

摘要

In colorectal cancer (CRC), overt metastases often appear after years of latency. But the signals that cause micro-metastatic cells to remain indolent, thereby enabling them to survive for extended periods of time, are unclear. Immunofluorescence and co-immunoprecipitation assays were used to explore the co-localization of CCL7 and CCR2. Immunohistochemical (IHC) assays were employed to detect the characters of metastatic HT29 cells in mice liver. Flow cytometry assays were performed to detect the immune cells. Bruberin vivo MS FX Pro Imager was used to observe the liver metastasis of CRC in mice. Quantitative real-time PCR (qRT-PCR) and western blot were employed to detect the expressions of related proteins. Trace RNA sequencing was employed to identify differentially expressed genes in MDSCs from liver micro-M and macro-M of CRC in mice. Here, we firstly constructed the vitro dormant cell models and metastatic dormant animal models of colorectal cancer. Then we found that myeloid-derived suppressor cells (MDSCs) were increased significantly from liver micro-metastases to macro-metastases of CRC in mice. Moreover, monocytic MDSCs (Mo-MDSC) significantly promoted the dormant activation of micro-metastatic cells compared to polymorphonuclear MDSCs (PMN-MDSC). Mechanistically, CCL7 secreted by Mo-MDSCs bound with membrane protein CCR2 of micro-metastatic cells and then stimulated the JAK/STAT3 pathway to activate the dormant cells. Low-dose administration of CCL7 and MDSCs inhibitors in vivo could significantly maintain the CRC metastatic cells dormant status for a long time to reduce metastasis or recurrence after radical operation. Clinically, the level of CCL7 in blood was positively related to the number of Mo-MDSCs in CCR patients, and highly linked with the short-time recurrence and distant metastasis. CCL7 secreted by Mo-MDSCs plays an important role in initiating the outgrowth of metastatic latent CRC cells. Inhibition of CCL7 might provide a potential therapeutic strategy for the prevention of metastasis recurrence.

学科与关键词

关键词
SUPPRESSOR-CELLS CORRELATEEARLY DISSEMINATIONPROMOTERECRUITMENTMECHANISMSDORMANCYSTAGE
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2021-05-13
卷期
第 12 卷, 第 5 期
页码
484
DOI
10.1038/s41419-021-03698-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China [2017YFC1309002]; National Natural Science Foundation of China [81872041, 81802306, 81903002]; Luzhou Science and Technology Program [2020-JYJ-42]; China Postdoctoral Science Foundation [2019M652963]; Natural Science Foundation of Guangdong Province [2018B0303110017, 2018A030310457, 2019A1515011436]; Doctoral Research Initiation Fund of Affiliated Hospital of Southwest Medical University

作者

  • R

    Ren, Xiaoli (第一作者)

    southern med univ

  • X

    Xiao, Jianbiao

    southern med univ

查看全部 12 位作者收起作者
  • Z

    Zhang, Wanning

    southern med univ

  • W

    Wang, Feifei

    southern med univ

  • Y

    Yan, Yongrong

    southern med univ

  • W

    Wu, Xuehui

    southern med univ

  • Z

    Zeng, Zhicheng

    southern med univ

  • H

    He, Yumei

    southern med univ

  • Y

    Yang, Wei

    southern med univ

  • L

    Liao, Wangjun

    southern med univ

  • D

    Ding, Yanqing

    southern med univ

  • L

    Liang, Li (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417